Close

Shire's (SHPG) ONIVYDE Receives EC Marketing Authorization for Treatment of Metastatic Adenocarcinoma of the Pancreas

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. TSLA
2. ENPH
3. TXN
4. BA
5. SPOT
6. META
7. IBM
8. V
9. KMB
10. MSFT


Go back to Shire's (SHPG) ONIVYDE Receives EC Marketing Authorization for Treatment of Metastatic Adenocarcinoma of the Pancreas
(NYSE: BXLT) Delayed: 46.02 --0 (-0%)
Previous Close $46.02    52 Week High $46.52 
Open $16.43    52 Week Low $29.83 
Day High $46.02    P/E N/A 
Day Low $46.02    EPS $0.00 
Volume 72,381       

MERRIMACK PHARM (NASDAQ: MACK) Delayed: 14.71 -0.02 (0.14%)
Previous Close $14.73    52 Week High $9.63 
Open $14.71    52 Week Low $4.39 
Day High $14.77    P/E N/A 
Day Low $14.71    EPS $-1.24 
Volume 106,490       

ShangPharma Corp. ADS (NYSE: SHP) Delayed: 8.95 --0 (-0%)
Previous Close $8.95    52 Week High $26.30 
Open $8.95    52 Week Low $26.03 
Day High $8.95    P/E N/A 
Day Low $8.95    EPS $0.00 
Volume 1,942,335       

Shire pic (NASDAQ: SHPG) Delayed: 179.20 +101.90 (131.82%)
Previous Close $77.30    52 Week High $219.52 
Open $77.29    52 Week Low $147.60 
Day High $77.49    P/E N/A 
Day Low $179.20    EPS $0.00 
Volume 302,425